Antidepressant Initiation in Drug-resistant Epilepsy: Risks and Benefits of Serotonin Selective Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors

Unique Quality of Life Priorities for People with Epilepsy and Comorbid Non-epileptic spells